For: | Miao YD, Tang XL, Wang JT, Mi DH. Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis. World J Gastroenterol 2022; 28(30): 4221-4226 [PMID: 36157115 DOI: 10.3748/wjg.v28.i30.4221] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i30/4221.htm |
Number | Citing Articles |
1 |
Syeda Mahak Zahra Bokhari, Peter Hamar. Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors. International Journal of Molecular Sciences 2023; 24(17): 13317 doi: 10.3390/ijms241713317
|
2 |
Shaoping Liu, Yinzhi Wei, Lei Nie, Ze Tang, Qi Lu, Qun Liang. Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12356-w
|
3 |
Jing Liu, Qianyu Du, Yu Shao, Han Xu, Xiuli Liu, Wenting Zhang, Mingxi Wang, Zhengguang Zhou, Qingsheng Kan, Yan Yang. Real-world status, efficacy and prognosis analysis of first-line treatment for unresectable hepatocellular carcinoma in patients treated at multiple centres. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2393291
|
4 |
Yonghui Ma, Guanming Shao, Yuwei Xie, Dongxia Yang, Kun Li, Bin Tan, Cong Wang, Peng Sun, Jingyu Cao. Multiomics Analysis of Interleukin-21 as a Potential Immunologic and Biomarker in Hepatocellular Carcinoma. Journal of Immunotherapy 2024; 47(7): 266 doi: 10.1097/CJI.0000000000000526
|